Next Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
$97K Buy
12,126
+1,526
+14% +$12.2K 0.01% 1184
2021
Q3
$104K Buy
10,600
+164
+2% +$1.61K 0.01% 1093
2021
Q2
$103K Sell
10,436
-372
-3% -$3.67K 0.01% 1098
2021
Q1
$125K Buy
10,808
+3,312
+44% +$38.3K 0.01% 934
2020
Q4
$72K Sell
7,496
-7,414
-50% -$71.2K 0.01% 1080
2020
Q3
$134K Buy
+14,910
New +$134K 0.01% 758
2020
Q2
Sell
-6,824
Closed -$61K 1778
2020
Q1
$61K Buy
6,824
+2,969
+77% +$26.5K 0.01% 921
2019
Q4
$38K Sell
3,855
-546
-12% -$5.38K ﹤0.01% 1303
2019
Q3
$30K Buy
4,401
+125
+3% +$852 ﹤0.01% 1308
2019
Q2
$39K Buy
4,276
+3,394
+385% +$31K ﹤0.01% 1245
2019
Q1
$14K Sell
882
-2,764
-76% -$43.9K ﹤0.01% 1045
2018
Q4
$56K Buy
3,646
+2,479
+212% +$38.1K 0.01% 774
2018
Q3
$25K Buy
+1,167
New +$25K 0.01% 719
2017
Q4
Sell
-9,877
Closed -$148K 1296
2017
Q3
$148K Sell
9,877
-697
-7% -$10.4K 0.04% 393
2017
Q2
$351K Buy
10,574
+6,350
+150% +$211K 0.09% 244
2017
Q1
$133K Sell
4,224
-4,297
-50% -$135K 0.04% 413
2016
Q4
$309K Buy
8,521
+1,383
+19% +$50.2K 0.05% 347
2016
Q3
$328K Buy
7,138
+2,401
+51% +$110K 0.06% 332
2016
Q2
$237K Buy
4,737
+575
+14% +$28.8K 0.08% 266
2016
Q1
$222K Buy
4,162
+1,175
+39% +$62.7K 0.08% 266
2015
Q4
$196K Sell
2,987
-475
-14% -$31.2K 0.07% 284
2015
Q3
$195K Hold
3,462
0.07% 288
2015
Q2
$204K Sell
3,462
-200
-5% -$11.8K 0.07% 294
2015
Q1
$228K Buy
3,662
+150
+4% +$9.34K 0.07% 291
2014
Q4
$202K Sell
3,512
-2,328
-40% -$134K 0.07% 305
2014
Q3
$314K Buy
5,840
+5,754
+6,691% +$309K 0.06% 335
2014
Q2
$4K Buy
+86
New +$4K ﹤0.01% 988